Published in Ann Surg on November 01, 2007
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10
Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol (2012) 1.69
Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer (2013) 1.38
A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation. PLoS One (2011) 1.32
Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol (2012) 1.30
C-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic Review. PLoS One (2015) 1.03
Identification of prognostic inflammatory factors in colorectal liver metastases. BMC Cancer (2014) 1.02
Liver-directed therapies in metastatic colorectal cancer. J Gastrointest Oncol (2014) 0.97
Surgery for colorectal liver metastases: The evolution of determining prognosis. World J Gastrointest Oncol (2013) 0.95
Predictors of long-term survival in patients with colorectal liver metastases: a single center study and review of the literature. Int J Colorectal Dis (2011) 0.93
Inflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patients. Biomed Res Int (2014) 0.91
Prognostic scores for colorectal liver metastasis: clinically important or an academic exercise? HPB (Oxford) (2010) 0.90
Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford) (2011) 0.86
Association of the Preoperative Neutrophil-to-ymphocyte Count Ratio and Platelet-to-Lymphocyte Count Ratio with Clinicopathological Characteristics in Patients with Papillary Thyroid Cancer. Endocrinol Metab (Seoul) (2015) 0.85
Changes in neutrophil/lymphocyte and platelet/lymphocyte ratios after chemotherapy correlate with chemotherapy response and prediction of prognosis in patients with unresectable gastric cancer. Oncol Lett (2015) 0.84
Elevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery. Int Surg (2015) 0.84
Operative terminology and post-operative management approaches applied to hepatic surgery: Trainee perspectives. World J Gastrointest Surg (2013) 0.83
Liver transplantation for hepatocellular carcinoma: role of inflammatory and immunological state on recurrence and prognosis. World J Gastroenterol (2013) 0.83
Evaluation of peri-operative chemotherapy using a prognostic nomogram for survival after resection of colorectal liver metastases. HPB (Oxford) (2009) 0.82
Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases. Ann Surg Oncol (2015) 0.82
Association Between the Neutrophil/Lymphocyte Ratio and Acute Kidney Injury After Cardiovascular Surgery: A Retrospective Observational Study. Medicine (Baltimore) (2015) 0.81
Metastatic liver disease from non-colorectal, non-neuroendocrine, non-sarcoma cancers: a systematic review. World J Surg Oncol (2015) 0.80
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases. Clin Cancer Res (2016) 0.79
Oligometastasis and oligo-recurrence: more than a mirage. Radiat Oncol (2014) 0.79
Defining patient outcomes in stage IV colorectal cancer: a prospective study with baseline stratification according to disease resectability status. Br J Cancer (2010) 0.79
Postoperative complications affect long-term survival outcomes following hepatic resection for colorectal liver metastasis. World J Surg (2015) 0.78
Determinants of long-term outcome in patients undergoing simultaneous resection of synchronous colorectal liver metastases. PLoS One (2014) 0.78
Feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study. Surg Today (2012) 0.78
Neoadjuvant and conversion treatment of patients with colorectal liver metastasis: the potential role of bevacizumab and other antiangiogenic agents. Target Oncol (2015) 0.78
A proposed new method for assessing the pathological response to chemotherapy in resected colorectal liver metastases. Br J Cancer (2014) 0.77
Can we improve the clinical risk score? The prognostic value of p53, Ki-67 and thymidylate synthase in patients undergoing radical resection of colorectal liver metastases. HPB (Oxford) (2013) 0.77
Preoperative selection of patients with colorectal cancer liver metastasis for hepatic resection. World J Gastroenterol (2016) 0.76
Determinants of short- and long-term outcome in patients undergoing simultaneous resection of colorectal cancer and synchronous colorectal liver metastases. Int J Colorectal Dis (2011) 0.76
The case for neo-adjuvant chemotherapy. For. Ann R Coll Surg Engl (2008) 0.75
Intra-arterial hepatic chemotherapy for unresectable colorectal liver metastases: a review of medical devices complications in 3172 patients. Med Devices (Auckl) (2009) 0.75
Preoperative peripheral blood neutrophil count predicts long-term outcomes following hepatic resection for colorectal liver metastases. Oncol Lett (2017) 0.75
Repeat hepatectomy is independently associated with favorable long-term outcome in patients with colorectal liver metastases. Cancer Med (2017) 0.75
Centralization of Liver Cancer Surgery and Impact on Multidisciplinary Teams Working on Stage IV Colorectal Cancer. Oncol Rev (2017) 0.75
Extracapsular lymph node involvement is associated with colorectal liver metastases and impact outcome after hepatectomy for colorectal metastases. World J Surg (2014) 0.75
Postoperative peripheral blood monocyte count correlates with postoperative bile leakage in patients with colorectal liver metastases after hepatic resection. Langenbecks Arch Surg (2013) 0.75
Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol (2011) 2.10
Liver transplantation for neuroendocrine tumors in Europe-results and trends in patient selection: a 213-case European liver transplant registry study. Ann Surg (2013) 1.98
Impact of margin status on survival following pancreatoduodenectomy for cancer: the Leeds Pathology Protocol (LEEPP). HPB (Oxford) (2009) 1.67
Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol (2008) 1.64
Right hepatic trisectionectomy for hepatobiliary diseases: results and an appraisal of its current role. Ann Surg (2007) 1.62
Pancreatico-duodenectomy for complicated groove pancreatitis. HPB (Oxford) (2007) 1.55
Should we use living donor grafts for patients with hepatocellular carcinoma? Ethical considerations. Liver Transpl (2011) 1.52
Hepatic resection and transplantation for primary carcinoid tumors of the liver. Ann Surg (2004) 1.49
Correlation between postoperative infective complications and long-term outcomes after hepatic resection for colorectal liver metastasis. Ann Surg (2010) 1.45
Pretransplant MELD score and post liver transplantation survival in the UK and Ireland. Liver Transpl (2004) 1.45
The value of intraoperative ultrasound during hepatic resection compared with improved preoperative magnetic resonance imaging. Eur J Ultrasound (2003) 1.43
A simple prophylaxis regimen for MRSA: its impact on the incidence of infection in patients undergoing liver resection. Ann R Coll Surg Engl (2009) 1.42
Outcomes in right liver lobe transplantation: a matched pair analysis. Transpl Int (2008) 1.40
Surgical strategy for cystic diseases of the liver in a western hepatobiliary center. World J Surg (2002) 1.28
Liver transplantation following donation after cardiac death: an analysis using matched pairs. Liver Transpl (2009) 1.13
Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium- and SPIO-enhanced MR imaging. Radiology (2005) 1.09
The combined organ effect: protection against rejection? Ann Surg (2008) 1.07
Inferior vena cava resection with hepatectomy: challenging but justified. HPB (Oxford) (2011) 1.06
Hemoperitoneum secondary to rupture of cystic artery pseudoaneurysm. Hepatobiliary Pancreat Dis Int (2007) 1.04
Donor risk index and MELD interactions in predicting long-term graft survival: a single-centre experience. Transplantation (2009) 1.04
Outcomes after major hepatectomy in elderly patients. J Am Coll Surg (2006) 1.03
Left hepatic trisectionectomy for hepatobiliary malignancy: results and an appraisal of its current role. Ann Surg (2005) 1.01
Surgical technique and systemic inflammation influences long-term disease-free survival following hepatic resection for colorectal metastasis. J Surg Oncol (2008) 0.99
Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci (2009) 0.99
Bile duct strictures after hepatobiliary surgery: assessment with MR cholangiography. Radiology (2004) 0.98
Treatment and surveillance of polypoid lesions of the gallbladder in the United Kingdom. HPB (Oxford) (2012) 0.97
Colorectal hepatic metastases: detection with SPIO-enhanced breath-hold MR imaging--comparison of optimized sequences. Radiology (2003) 0.97
Index admission laparoscopic cholecystectomy for patients with acute biliary symptoms: results from a specialist centre. HPB (Oxford) (2010) 0.96
Retroperitoneal enteric duplication cyst presenting as a pancreatic cystic lesion. A case report. JOP (2006) 0.96
Indication for treatment and long-term outcome of focal nodular hyperplasia. HPB (Oxford) (2007) 0.94
Patient views through the keyhole: new perspectives on single-incision vs. multiport laparoscopic cholecystectomy. HPB (Oxford) (2012) 0.94
The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases. Gastroenterology (2003) 0.94
Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl (2013) 0.93
Hepatocellular carcinoma within a noncirrhotic, nonfibrotic, seronegative liver: surgical approaches and outcomes. J Am Coll Surg (2011) 0.91
Portal vein arterialization as a salvage procedure during left hepatic trisectionectomy for hilar cholangiocarcinoma. J Am Coll Surg (2008) 0.90
Large hepatocellular carcinoma: time to stop preoperative biopsy. J Am Coll Surg (2007) 0.89
Prognostic utility of postoperative C-reactive protein for posthepatectomy liver failure. Arch Surg (2008) 0.89
Kinetics of liver function tests after a hepatectomy for colorectal liver metastases predict post-operative liver failure as defined by the International Study Group for Liver Surgery. HPB (Oxford) (2012) 0.88
Interaction of tumour biology and tumour burden in determining outcome after hepatic resection for colorectal metastases. HPB (Oxford) (2010) 0.88
The radiological management of pseudoaneurysms complicating pancreatitis. JOP (2012) 0.88
Predictors of blood transfusion requirement in elective liver resection. HPB (Oxford) (2010) 0.88
Metabonomics: a useful tool for the future surgeon. J Surg Res (2009) 0.88
Xanthogranulomatous cholecystitis: a European and global perspective. HPB (Oxford) (2013) 0.87
Acceptable outcome after kidney transplantation using "expanded criteria donor" grafts. Transplantation (2010) 0.87
One-millimeter cancer-free margin is curative for colorectal liver metastases: a propensity score case-match approach. Ann Surg (2014) 0.87
Evolution of the surgical management of perihilar cholangiocarcinoma in a Western centre demonstrates improved survival with endoscopic biliary drainage and reduced use of blood transfusion. HPB (Oxford) (2011) 0.86
Total laparoscopic pancreaticoduodenectomy and reconstruction for a cholangiocarcinoma of the bile duct. J Laparoendosc Adv Surg Tech A (2007) 0.84
Repeat liver resection after a hepatic or extended hepatic trisectionectomy for colorectal liver metastasis. HPB (Oxford) (2013) 0.84
Subtotal hepatectomy and whole graft auxiliary transplantation for acetaminophen-associated acute liver failure. HPB (Oxford) (2013) 0.84
A combined liver-pancreas en-bloc transplant in a patient with cystic fibrosis. Transplantation (2005) 0.84
Identification and use of the putative Bacteroides ovatus xylanase promoter for the inducible production of recombinant human proteins. Microbiology (2008) 0.84
Ischemia- reperfusion injury and its influence on the epigenetic modification of the donor kidney genome. Transplantation (2008) 0.84